Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 20,367Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14EXELIXIS

02 45EXELIXIS INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 8877776

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203756

Patent Use Code : U-1617

Delist Requested :

Patent Use Description : METHOD OF TREATING MED...

Patent Expiration Date : 2030-10-08

blank

02

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 10039757

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-1480

Delist Requested :

Patent Use Description : TREATMENT OF ADVANCED ...

Patent Expiration Date : 2031-07-18

blank

03

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 10034873

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-2488

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-07-18

blank

04

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 8497284

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-1220

Delist Requested :

Patent Use Description : TREATMENT OF RENAL CEL...

Patent Expiration Date : 2024-09-24

blank

05

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 8497284

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-1220

Delist Requested :

Patent Use Description : TREATMENT OF RENAL CEL...

Patent Expiration Date : 2024-09-24

blank

06

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 10034873

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-2488

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-07-18

blank

07

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 8497284

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-1220

Delist Requested :

Patent Use Description : TREATMENT OF RENAL CEL...

Patent Expiration Date : 2024-09-24

blank

08

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 8497284

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-2488

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-09-24

blank

09

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 8497284

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-1480

Delist Requested :

Patent Use Description : TREATMENT OF ADVANCED ...

Patent Expiration Date : 2024-09-24

blank

10

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 8497284

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-2488

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-09-24

blank